DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Cortés J, Lipatov O, Im S. et al.
KEYNOTE-119: Phase 3 study of pembrolizumab (pembro) versus single-agent
chemotherapy (chemo) for metastatic triple-negative breast cancer (mTNBC).
Ann Oncol 2019;
30: v851-v934
DOI: 10.1093/annonc/mdz394.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.